Technology plays a huge role in enabling the pharma and life sciences industry to achieve advanced and futuristic objectives. It throws open doors for new possibilities and opportunities. Identifying the broad spectrum of possible advancements in the pharma and life science sector, Calyx, a company that delivers more value to help the global biopharmaceutical industry bring the much-needed treatments to patients, came into the market. With decades of experience to back them off, along with advanced technology, and the industry’s brilliant minds, Calyx will help in bringing futuristic treatments to market. Calyx turns uncertain into reliable and helps bring new medical treatments to market faster.
Being the leading eClinical and Regulatory solutions and services provider most relied on to solve complex data challenges in clinical research, Calyx takes its responsibility very seriously. It takes every step with particular caution and care. With deep expertise in clinical development and more than 25 years of supporting trial sponsors and clinical research organizations, Calyx makes use of its intelligence and experience to solve complex problems, deliver fast insights, and get new drugs to market every day.
Calyx offers many solutions for its customers. Calyx’s Interactive Response Technology(IRT) solution optimizes the randomization and clinical trial supply management processes and drives the development program forward. With over 20 years of experience in regulatory compliance, Calyx’s best in class Regulatory Information Management (RIM) system ensures to meet the regulatory requirements worldwide. Industry-leading clinical trial management and comprehensive medical imaging are also some of the advanced solutions Calyx offers.
Recently, one of the world’s Top 10 pharmaceutical companies implemented a contract to continue using the Calyx Regulatory Information Management (RIM) system for critical submissions of clinical development data to global regulators through 2026. The Calyx RIM publishing module allows pharmaceutical companies to compile and present comprehensive dossiers to international regulatory authorities. Designed by Calyx in-house regulatory experts, Calyx RIM is a certified, vital tool that optimizes the regulatory submission process and is continually updated. The value of the RIM system is further increased through Calyx’s partnership with Microsoft and its use of innovative, cloud-based technology. Calyx RIM on Microsoft Azure provides tailored, direct system updates based on users’ needs and schedules, ensuring minimal disruption and ongoing compliance with global regulatory requirements.
As part of the expansion and to satisfy the growing demand, Calyx opened its US headquarters in Morrisville, North Carolina. Adjacent to Research Triangle Park (RTP), the facility was selected for its proximity to many of Calyx’s clients, including some of the industry’s largest pharmaceutical companies and clinical research organizations.
“The opening of our US headquarters is representative of the high value we place on our customer relationships,” says Gavin Nichols, CEO of Calyx. “Working closely with these many successful clinical trial sponsors and CROs – and leveraging the rich pool of experienced industry talent in the area – enables us to continue our mission of providing the innovative technology solutions and services our customers need to speed the discovery of new treatments,” he added.
Calyx is dedicated to shaping the future of clinical research. With a global footprint, robust operational infrastructure, and deep scientific knowledge, Calyx solves complex clinical development challenges. Calyx’s solutions have been used in the clinical development of over 650 approved medical treatments, and over 70 of those are treatments that received Breakthrough Therapy designation. They are now helping patients with severe conditions see a considerable improvement compared to other available therapies. Their leadership team is comprised of a diverse group of industry and technology veterans whose experience in advancing life sciences is second to none.
Company:
Calyx
Management:
Gavin Nichols, CEO
Description:
Calyx is a company that delivers more value to help the global biopharmaceutical industry bring much-needed treatments to patients. With deep expertise in clinical development and more than 25 years of supporting trial sponsors and clinical research organizations, Calyx makes use of its intelligence and experience to solve complex problems, deliver fast insights, and get new drugs to market every day.
